Shandong Xinhua Pharmaceutical Company Limited (XIN) — Long-term Investment Intensity
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Long-term Investment Intensity of 4.6% as of December 2019. Long-term investments of €296.25 Million represent 4.6% of total assets of €6.44 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Shandong Xinhua Pharmaceutical Company L asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Shandong Xinhua Pharmaceutical Company Limited Long-term Investment Intensity (2013–2019)
This chart shows how Shandong Xinhua Pharmaceutical Company Limited's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 4.6%, reflecting long-term investments of €296.25 Million against total assets of €6.44 Billion EUR. For the complete balance sheet picture, see Shandong Xinhua Pharmaceutical Company L balance sheet assets.
Annual Long-term Investment Intensity for Shandong Xinhua Pharmaceutical Company Limited (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Shandong Xinhua Pharmaceutical Company L balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.6% | €296.25 Million | €6.44 Billion | ▲ +1.4 pp |
| 2018 | 3.2% | €189.74 Million | €5.92 Billion | ▼ -1.7 pp |
| 2017 | 4.9% | €258.14 Million | €5.27 Billion | ▲ +0.9 pp |
| 2016 | 4.0% | €189.47 Million | €4.72 Billion | ▼ -0.4 pp |
| 2015 | 4.5% | €200.43 Million | €4.49 Billion | ▼ -0.7 pp |
| 2014 | 5.2% | €220.59 Million | €4.25 Billion | ▲ +2.0 pp |
| 2013 | 3.2% | €127.41 Million | €4.01 Billion | — |